Nuvo Pharmaceuticals Inc (NRI):製薬・医療:M&Aディール及び事業提携情報

GlobalDataが発行した調査報告書(DATA904C5160)
◆英語タイトル:Nuvo Pharmaceuticals Inc (NRI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C5160
◆発行会社(リサーチ会社):GlobalData
◆発行日:2018年9月
◆ページ数:49
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Summary
Nuvo Pharmaceuticals Inc (Nuvo), formerly Nuvo Research Inc, is a healthcare company that offers portfolio of commercial products and pharmaceutical manufacturing capabilities. The company’s product portfolio includes pennsaid, heated lidocaine and tetracaine patches. Its products deliver drugs topically into and through the skin to the specific site of activity. Nuvo’s pennsaid and transdermal drug carriers are used for the treatment of osteoarthritis of the knee; and heated lidocaine or tetracaine patch, is a topical patch that combines lidocaine, tetracaine and heat using proprietary controlled heat-assisted drug delivery technology. The company operates through its manufacturing facility located in Varennes, Quebec. It markets its products through a network of distributors. Nuvo Pharmaceuticals is headquartered in Mississauga, Ontario, Canada.

Nuvo Pharmaceuticals Inc (NRI) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Nuvo Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Nuvo Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Nuvo Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Nuvo Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Nuvo Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 9
Nuvo Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Nuvo Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 12
Asset Purchase 12
Nuvo Pharma to Acquire Pharma Business from Aralez Pharma for USD110 Million 12
Nuvo Pharma Acquires Ex-US Rights to Resultz from Piedmont Pharma for USD7 Million 14
Nuvo Research Reacquires Pennsaid Rights from Paladin Labs 15
Partnerships 16
Nuvo Research Enters Into Co-Development Agreement With Ferndale Labs And Contract Research Organization 16
Nuvo Research Enters Into Distribution Agreement With NovaMedica For Pennsaid 17
Licensing Agreements 18
Gebro Pharma Enters into Licensing Agreement with Nuvo Pharma 18
Sayre Therapeutics Enters into Licensing Agreement with Nuvo Pharma 19
Nuvo Research Enters into Licensing Agreement with Galderma Pharma for Pliaglis 20
Nuvo Research Enters Into Licensing Agreement With Paladin Labs For Synera 21
Equity Offering 22
Nuvo Research Completes Private Placement Of Units For US$2.8 Million 22
Asset Transactions 23
Horizon Pharma Acquires US Rights to Pennsaid 2% from Nuvo Research for USD45 Million 23
Galen Acquires US Rights For Synera From Nuvo Research For USD14.5 Million 25
Tioga Acquires HTE Formulation Patents from Nuvo Research 26
Nuvo Pharmaceuticals Inc – Key Competitors 27
Nuvo Pharmaceuticals Inc – Key Employees 28
Nuvo Pharmaceuticals Inc – Locations And Subsidiaries 29
Head Office 29
Other Locations & Subsidiaries 29
Recent Developments 30
Financial Announcements 30
Aug 02, 2018: Nuvo Pharmaceuticals announces 2018 second quarter results 30
May 10, 2018: Nuvo Pharmaceuticals Announces 2018 First Quarter Results 32
Mar 23, 2018: Nuvo Pharmaceuticals Announces 2017 Fourth Quarter and Year-End Results 34
Nov 01, 2017: Nuvo Pharmaceuticals Announces 2017 Third Quarter Results 36
Aug 09, 2017: Nuvo Pharmaceuticals Announces 2017 Second Quarter Results 39
May 10, 2017: Nuvo Pharmaceuticals Announces 2017 First Quarter Results 42
Mar 01, 2017: Nuvo Pharmaceuticals Announces 2016 Year-End and Fourth Quarter Results 44
Corporate Communications 47
Nov 22, 2017: Nuvo Pharmaceuticals Announces Appointment of Jesse Ledger as President & Chief Executive Officer 47
Legal and Regulatory 48
Aug 20, 2018: Nuvo Pharmaceuticals announces extension of exclusivity period with Aralez and Deerfield 48
Appendix 49
Methodology 49
About GlobalData 49
Contact Us 49
Disclaimer 49

List of Tables
Nuvo Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Nuvo Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Nuvo Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Nuvo Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Nuvo Pharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Nuvo Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 9
Nuvo Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Nuvo Pharma to Acquire Pharma Business from Aralez Pharma for USD110 Million 12
Nuvo Pharma Acquires Ex-US Rights to Resultz from Piedmont Pharma for USD7 Million 14
Nuvo Research Reacquires Pennsaid Rights from Paladin Labs 15
Nuvo Research Enters Into Co-Development Agreement With Ferndale Labs And Contract Research Organization 16
Nuvo Research Enters Into Distribution Agreement With NovaMedica For Pennsaid 17
Gebro Pharma Enters into Licensing Agreement with Nuvo Pharma 18
Sayre Therapeutics Enters into Licensing Agreement with Nuvo Pharma 19
Nuvo Research Enters into Licensing Agreement with Galderma Pharma for Pliaglis 20
Nuvo Research Enters Into Licensing Agreement With Paladin Labs For Synera 21
Nuvo Research Completes Private Placement Of Units For US$2.8 Million 22
Horizon Pharma Acquires US Rights to Pennsaid 2% from Nuvo Research for USD45 Million 23
Galen Acquires US Rights For Synera From Nuvo Research For USD14.5 Million 25
Tioga Acquires HTE Formulation Patents from Nuvo Research 26
Nuvo Pharmaceuticals Inc, Key Competitors 27
Nuvo Pharmaceuticals Inc, Key Employees 28
Nuvo Pharmaceuticals Inc, Subsidiaries 29

List of Figures
Nuvo Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Nuvo Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Nuvo Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Nuvo Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Nuvo Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Nuvo Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Nuvo Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Nuvo Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Nuvo Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 9

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ Nuvo Pharmaceuticals Inc (NRI):製薬・医療:M&Aディール及び事業提携情報(Nuvo Pharmaceuticals Inc (NRI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆